Kunyu Yang

10.7k citations
176 papers · 4.6k · 2 hit papers · h-index 36

Impact in

    • Head and Neck Cancer Studies
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis

Papers in

    • Cancer Immunotherapy and Biomarkers 25
    • Lung Cancer Research Studies 15
    • Peptidase Inhibition and Analysis 9

Kunyu Yang

163 papers receiving 4.5k citations

Kunyu Yang's Hit Papers

Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer 2021 · 264 citations
2640+4+9Years since publication100200300400

Peers

Kunyu Yang
Comparison fields: 5 of 131
  • Otorhinolaryngology 517
  • Oncology 1.3k
  • Cancer Research 686
  • Pulmonary and Respiratory Medicine 1.1k
  • Immunology 606
Replace Michael T. Spiotto with:
Michael T. Spiotto United States
Luitpold Distel Germany
Neil Senzer United States
Ekkehard Dikomey Germany
Nils Cordes Germany
Sandra Nuyts Belgium
Donna S. Shewach United States
Willy Landuyt Belgium
Claire Vanpouille‐Box United States
Nikolai N. Khodarev United States
Kunyu Yang relative to Michael T. Spiotto United States Michael T. Spiotto's profile →
Citations per field
00.5×2.7×
Michael T. Spiotto · 1×
Citations per year

Countries citing papers authored by Kunyu Yang

Since Specialization
Citations

This map shows the geographic impact of Kunyu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunyu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunyu Yang more than expected).

Fields of papers citing papers by Kunyu Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kunyu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunyu Yang. The network helps show where Kunyu Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Kunyu Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kunyu Yang Line = papers co-authored together Kunyu Yang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma
Hit paper breakdown →
2012471
2 2012293
3
Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer
Hit paper breakdown →
2021264
4 2020209
5 2009207
6 2020195
7 2019160
8 2011119
9 200592
10 202187
11 202076
12 202376
13 202176
14 201770
15 202069
16 202163
17 200763
18 202056
19 202155
20 201455

About Kunyu Yang

Kunyu Yang is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Immunology, having authored 176 papers that have together received 4.6k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (27 papers), Cancer Immunotherapy and Biomarkers (25 papers), Lung Cancer Treatments and Mutations (17 papers), Immunotherapy and Immune Responses (15 papers), Lung Cancer Research Studies (15 papers), Nanoplatforms for cancer theranostics (11 papers), Immune cells in cancer (9 papers) and Peptidase Inhibition and Analysis (9 papers). The work is most often cited by research in Otorhinolaryngology (517 citations), Oncology (1.3k citations), Cancer Research (686 citations), Pulmonary and Respiratory Medicine (1.1k citations) and Immunology (606 citations). Kunyu Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Gang Wu, Chao Wan, Gang Wu, Honglin Jin, Sheng Zhang, Tao� Zhang, Jonathan F. Lovell, Yajie Sun, Gang Peng and Qin Li. Their work appears in journals such as Journal of Clinical Oncology, Theranostics, Annals of Oncology, International Journal of Radiation Oncology*Biology*Physics and International Journal of Radiation Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact